David Hastings

Currently holds a position at SCYNEXIS Inc

Position	Company	Period
Director	SCYNEXIS Inc	Sept. 24, 2015 -

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2025-02-05	2025-02-04	Arbutus Biopharma Corp (ABUS)	PlS Planned sale	74,128 +6.8% 296.45 US$1,633,628	74,128 +6.8%	296.45	US$1,633,628
2025-02-04	2025-02-04	Arbutus Biopharma Corp (ABUS)	PrS Proposed sale	96,700 108.05 US$1,513,614	96,700	108.05	US$1,513,614
2024-02-05	2024-02-02	Arbutus Biopharma Corp (ABUS)	PlS Planned sale	1,127 -12.5% 443.99 US$4,217,762	1,127 -12.5%	443.99	US$4,217,762